Keyphrases
Clinical Investigation
100%
Hemostasis
100%
Laboratory Investigation
100%
Aminocaproic Acid
100%
Lunate
90%
Bleeding Time
63%
Platelets
45%
Vessel Wall
18%
Intracranial Aneurysm
18%
Fibrinolytic Activity
18%
Adenosine Diphosphate
18%
Serotonin
9%
Functional Impairment
9%
Fibrinolysis
9%
Plasma Parameters
9%
Activity in Vivo
9%
Daily Dose
9%
Per Se
9%
Fibrinogen
9%
Continuous Infusion
9%
Platelet Aggregation
9%
Adenosine Triphosphate
9%
Chymotrypsin
9%
Human Aortic Endothelial Cells
9%
Collagen-induced
9%
Prostacyclin
9%
Supranormal
9%
Acid Infusion
9%
Vascular Component
9%
Wall Interaction
9%
Hemostatic Management
9%
Medicine and Dentistry
Blood Stasis
100%
Aminocaproic Acid
100%
Bleeding Time
63%
Platelet
45%
Fibrinolysis
27%
Adenosine Diphosphate
18%
Intracranial Aneurysm
18%
Infusion
9%
In Vitro
9%
Functional Disease
9%
Hemostat
9%
Endothelial Cell
9%
Thrombocyte Aggregation
9%
Continuous Infusion
9%
Serotonin
9%
Adenosine Triphosphate
9%
Prostacyclin
9%
Fibrinogen
9%
Chymotrypsin
9%
Pharmacology, Toxicology and Pharmaceutical Science
Blood Stasis
100%
Aminocaproic Acid
100%
Bleeding
54%
Fibrinolytic Agent
18%
Intracranial Aneurysm
18%
Adenosine Diphosphate
18%
Functional Disease
9%
Hemostatic Agent
9%
Adenosine Triphosphate
9%
Serotonin
9%
Prostacyclin
9%
Fibrinogen
9%
Chymotrypsin
9%